المنشورات
Today she is the author and co-author of chapters in books on gynecological oncology and about 150 articles published in national and international scientific journals. Her Hirsch index is 30.
أحدث المنشورات
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med. 2019 Sep 28
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators
قراءة المزيد
Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option.
Int J Gynecol Cancer. 2019 Nov;29(9):1431-1436. doi: 10.1136/ijgc-2019-000624. Epub 2019 Sep 18
Bergamini A, Bocciolone L, Fodor A, Candiani M, Mangili G.
قراءة المزيد
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease.
J Ultrasound Med. 2019 Aug 29
Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, Valsecchi L, Candiani M, Seckl MJ
قراءة المزيد
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study.
Gynecol Oncol. 2019 Aug;154(2):323-327.
Bergamini A, Cormio G, Ferrandina G, Lorusso D, Giorda G, Scarfone G, Bocciolone L, Raspagliesi F, Tateo S, Cassani C, Savarese A, Breda E, De Giorgi U, Mascilini F, Candiani M, Kardhashi A, Biglia N, Perrone AM, Pignata S, Mangili G.
قراءة المزيد
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
Gynecol Oncol. 2018 Dec;151(3):449-452
Mangili G, Cioffi R, Danese S, Frigerio L, Ferrandina G, Cormio G, Rabaiotti E, Scarfone G, Gadducci A, Bergamini A, Pisano C, Candiani M
قراءة المزيد
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
Eur J Surg Oncol. 2018
Bergamini A, Ferrandina G, Candiani M, Cormio G, Giorda G, Lauria R, Perrone AM, Scarfone G, Breda E, Savarese A, Frigerio L, Gadducci A, Mascilini F, Maneschi F, Cassani C, Marchetti C, Cecere SC, Biglia N, De Giorgi U, Raspagliesi F, Lorusso D, Mangili G
قراءة المزيد
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Int J Gynecol Cancer. 2018 Feb;28(2):332-337
Cioffi R, Bergamini A, Gadducci A, Cormio G, Giorgione V, Petrone M, Rabaiotti E, Pella F, Candiani M, Mangili G.
قراءة المزيد
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
Hum Reprod. 2018 Feb 1;33(2):181-187.
Peccatori FA, Mangili G, Bergamini A, Filippi F, Martinelli F, Ferrari F, Noli S, Rabaiotti E, Candiani M, Somigliana E.
قراءة المزيد
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Eur J Surg Oncol. 2019
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA RARECARENet Working Group.
قراءة المزيد
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
J Clin Oncol. 2017 Oct 10;35(29):3347-3353.
Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Piccirillo MC, Gallo C, Perrone F.
قراءة المزيد
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).
Ann Oncol. 2017 Aug 1;28(8):1910-1916.
De Giorgi U, Richard S, Badoglio M, Kanfer E, Bourrhis JH, Nicolas-Virelizier E, Vettenranta K, Lioure B, Martin S, Dreger P, Schuler MK, Thomson K, Scarpi E, Rosti G, Selle F, Mangili G, Lanza F, Bregni M; Solid Tumours Working Party (STWP) of the EBMT.
قراءة المزيد
Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer.
Acta Obstet Gynecol Scand. 2017 Aug;96(8):949-953
Sarais V, Paffoni A, Pagliardini L, Filippi F, Martinelli F, Mangili G, Candiani M, Papaleo E.
قراءة المزيد
Fertility preservation in women with borderline ovarian tumours.
Cancer Treat Rev. 2016 Sep;49:13-24
Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC, Candiani M, Peccatori F.
قراءة المزيد
The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Ann Oncol. 2017
Mangili G, Sigismondi C, Lorusso D, Cormio G, Candiani M, Scarfone G, Mascilini F, Gadducci A, Mosconi AM, Scollo P, Cassani C, Pignata S, Ferrandina G.
قراءة المزيد
Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Int J Gynecol Cancer. 2015 Feb;25(2):203-7.
Sigismondi C, Scollo P, Ferrandina G, Candiani M, Angioli R, Viganò R, Scarfone G, Mangili G.
قراءة المزيد
